Catalog No.
RXX51402
Species reactivity
Plasmodium falciparum (isolate 3D7)
Host species
Mouse
Isotype
IgG2a, kappa
Clonality
Monoclonal
Target
Merozoite surface antigen 2, MSA-2, 45 kDa merozoite surface antigen, MSA2, PFB0300c, Parasite
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P50498
Applications
ELISA, IF
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
4D11
Redefining an epitope of a malaria vaccine candidate, with antibodies against the N-terminal MSA-2 antigen of Plasmodium harboring non-natural peptide bonds., PMID:23836419
Age-dependent systemic antibody responses and immunisation-associated changes in mice orally and nasally immunised with Lactococcus lactis expressing a malaria parasite protein., PMID:19545652
Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunisations., PMID:16545511
Herpesvirus saimiri immortalization of Aotus T lymphocytes specific for an immunogenically modified peptide of Plasmodium falciparum merozoite surface antigen 2., PMID:15661043
Human leukocyte antigen class II alleles influence levels of antibodies to the Plasmodium falciparum asexual-stage apical membrane antigen 1 but not to merozoite surface antigen 2 and merozoite surface protein 1., PMID:15102786
[Humoral immune response in mice to hybrid nucleic acid vaccines containing Plasmodium falciparum merozoite surface protein 1 block 17-based gene]., PMID:12563865
Immune response induced by recombinant BCG expressing merozoite surface antigen 2 from Plasmodium falciparum., PMID:11738757
Human genetic factors related to susceptibility to mild malaria in Gabon., PMID:11196674
[Assessment of malaria DNA vaccines in mice and monkeys]., PMID:10887674
Two MSA 2 peptides that bind to human red blood cells are relevant to Plasmodium falciparum merozoite invasion., PMID:10727103
Mice immunised with synthetic peptide from N-terminal conserved region of merozoite surface antigen-2 of human malaria parasite Plasmodium falciparum can control infection induced by Plasmodium yoelii yoelii 265BY strain., PMID:10580206
Immune responses against Plasmodium falciparum asexual blood-stage antigens and disease susceptibility in Gabonese and Cameroonian children., PMID:10497996
Antibodies to a merozoite surface protein promote multiple invasion of red blood cells by malaria parasites., PMID:10417674
Heritability and segregation analysis of immune responses to specific malaria antigens in Papua New Guinea., PMID:10323182
Model multiple antigenic and homopolymeric peptides from non-repetitive sequences of malaria merozoite proteins elicit biologically irrelevant antibodies., PMID:9989251
Mammalian cell expression of malaria merozoite surface proteins and experimental DNA and RNA immunisation., PMID:9989240
Selection of an adjuvant for vaccination with the malaria antigen, MSA-2., PMID:9261951
Assessment of the humoral immune response against Plasmodium falciparum rhoptry-associated proteins 1 and 2., PMID:9169771
Atypical IgG subclass antibody responses to Plasmodium falciparum asexual stage antigens., PMID:15275101
Humoral response to defined Plasmodium falciparum antigens in cerebral and uncomplicated malaria and their relationship to parasite genotype., PMID:9158053
Plasmodium falciparum: genetic diversity of several strains infectious for the squirrel monkey (Saimiri sciureus)., PMID:8888729
Effect of context and adjuvant on the immunogenicity of recombinant proteins and peptide conjugates derived from the polymorphic malarial surface antigen MSA2., PMID:8821653
Safety, immunogenicity, and pilot efficacy of Plasmodium falciparum sporozoite and asexual blood-stage combination vaccine in Swiss adults., PMID:7485698
Relationship between humoral response to Plasmodium falciparum merozoite surface antigen-2 and malaria morbidity in a highly endemic area of Papua New Guinea., PMID:7985752
The influence of water-miscible alcohols on the conformation of antibodies directed against a defined epitope., PMID:7517232
Two immunogenic peptide conjugates derived from P. falciparum MSA2 give rise to antibodies that crossreact with a nonhomologous 195-kDa malarial protein., PMID:8400614
Antibody detection ELISAS for malaria diagnosis., PMID:1298085
A fourth family of the Plasmodium falciparum S-antigen., PMID:1474992
Protection of squirrel monkeys against virulent Plasmodium falciparum infections by use of attenuated parasites., PMID:1347760
Transcription of the gene for the merozoite surface antigen MSA2 of the human malaria parasite Plasmodium falciparum during the asexual cycle., PMID:1547892
Comparative study of the T cell response to two allelic forms of a malarial vaccine candidate protein., PMID:1371134
Protective immunization with invariant peptides of the Plasmodium falciparum antigen MSA2., PMID:1727867
Immunological fine structure of the variable and constant regions of a polymorphic malarial surface antigen from Plasmodium falciparum., PMID:1779984
Failure of recombinant vaccinia viruses expressing Plasmodium falciparum antigens to protect Saimiri monkeys against malaria., PMID:1711015
High-titer antisera production using three adjuvants and peptide conjugates derived from malarial surface antigen MSA-2., PMID:1823184
Comparative immunogenicity of free and carrier-conjugated peptides derived from the constant regions of a polymorphic malarial surface antigen., PMID:2060972
Structural and antigenic polymorphism of the 35- to 48-kilodalton merozoite surface antigen (MSA-2) of the malaria parasite Plasmodium falciparum., PMID:1990294
Antigenic diversity in Plasmodium falciparum., PMID:1820715
Sequence comparison of allelic forms of the Plasmodium falciparum merozoite surface antigen MSA2., PMID:2090943
Synthetic peptide immunogens eliciting antibodies to Plasmodium falciparum sporozoite and merozoite surface antigens in H-2b and H-2k mice., PMID:2212657
Peptide vaccines derived from a malarial surface antigen: effects of dose and adjuvants on immunogenicity., PMID:1697281
Analysis of human T cell response to two Plasmodium falciparum merozoite surface antigens., PMID:2479561
High titer response against a malarial antigen depends on the flanking sequence of the immunizing peptide conjugate., PMID:2520766
For research use only. Not for human or drug use.
